Filter posts

2014 BIO Investor Forum Fireside Chat with Nick Leschly and Chris Collins

Nick Leschly has served as bluebird bio’s president and chief executive officer since September 2010. …

Blurred Lines: Investors Explain Their Re-Thinking of Traditional Private-Only or Public-Only Invest...

The recent expansion and acceleration of the biotech stock market has seen a new willingness …

Electroceuticals and Digital Drug Delivery: Neurological Stimulation and Beyond

Some of the most experienced executives in biotechnology have begun asking themselves, “Can we foresee …

Biotech CEOs Talk JOBS Act and IPO Experiences at 2014 BIO Investor Forum

The JOBS Act has contributed to a dramatic acceleration in new biotech IPOs since its …

Upcoming Panel will Highlight The Successes of The NCATS Tech Transfer Model

On October 29, 2014 the Center for Clean Energy Innovation and the House Technology Transfer …

GMO Answers Marks October as "Get to Know GMOs" Month

GMO Answers has announced that for the month of October we are inviting the public to …